Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 913 53 Master Bottle Label Approval Rev A 01 21)

Label (51655 913 53 Master Bottle Label Approval Rev A 01 21)
NDC 51655-913-53 is a prescription medication composed of Ondansetron Orally Disintegrating Tablets. Each package includes 10 tablets, with a dosage as indicated in the package insert. The medication should be stored in its original container at a temperature range from 20-25°C, with excursions permitted between 15-30°C. It contains Phenylalanine per tablet, and each orally disintegrating tablet contains Ondansetron USP 4mg. The unit-dose blister pack is child-resistant and should only be removed just before usage. The medication must not be used if blisters are torn, broken, or missing. The medication is repackaged by Northwind Pharmaceuticals, Indianapolis, IN 46203, and manufactured by Rising Health LLC, with lot number 0000000000 and expiration date 00/00/0000.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.